Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001140361-25-031320
Filing Date
2025-08-14
Accepted
2025-08-14 17:29:02
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 ny20053995x1_424b5.htm 424B5 532730
2 logo_aquestive.jpg GRAPHIC 26566
  Complete submission text file 0001140361-25-031320.txt   570234
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-278498 | Film No.: 251221239
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)